NCT06440902View on ClinicalTrials.gov

Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA

PHASE2RecruitingINTERVENTIONAL
Enrollment

1,100

Participants

Timeline

Start Date

December 28, 2023

Primary Completion Date

September 1, 2028

Study Completion Date

September 1, 2028

Conditions
Colorectal Cancer Metastatic
Interventions
DRUG

Cetuximab

Cetuximab is given In patients with NeoRAS WT

Trial Locations (1)

200032

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER